Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,308,578
+$578,281 QoQ
Shares Held
1,091
+37.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,881
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knights of Columbus Asset Advisors LLC holds $16,766,377 across 10 Drug Manufacturers - General names. LLY ranks #2 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
109,712 | $13,861,014 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,091 | $1,308,578 | |
| 3 | JNJ |
Johnson & Johnson
|
1,421 | $360,891 | |
| 4 | ABBV |
AbbVie Inc.
|
1,391 | $350,031 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
4,940 | $284,642 | |
| 6 | NVS |
Novartis AG
|
1,585 | $248,401 | |
| 7 | NVO |
Novo Nordisk A S
|
2,931 | $140,512 | |
| 8 | SNY |
Sanofi
|
2,405 | $102,597 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,308,578 | 1,091 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $730,297 | 794 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $662,002 | 616 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $296,807 | 389 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $664,159 | 852 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $718,541 | 870 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $777,404 | 1,007 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $963,016 | 1,087 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $864,637 | 955 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $756,955 | 973 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $735,062 | 1,261 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $909,898 | 1,694 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $777,099 | 1,657 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $622,277 | 1,812 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $15,069,681 | 41,192 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $13,966,456 | 43,193 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $14,192,843 | 43,774 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,231,391 | 4,300 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,168,134 | 4,229 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $738,666 | 3,197 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $495,074 | 2,157 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,447,250 | 23,805 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,146,620 | 36,405 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,193,429 | 35,086 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,141,009 | 43,495 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,564,581 | 32,905 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||